 |
Case Report
Life-threatening retroperitoneal bleeding in coronavirus disease 2019 patient while on full dose anticoagulation: A case report
1 MD, Internal Medicine Resident, East Tennessee State University, Johnson City, TN, United States
2 MD, Internal Medicine Physician, James H. Quillen Veterans Affairs Medical Center, Johnson City, TN, United States
Address correspondence to:
Kirandeep Kaur
2020 Indian Ridge Rd, Apt #225, Johnson City, TN 37604,
United States
Message to Corresponding Author
Article ID: 101332Z01KK2022
Access full text article on other devices
Access PDF of article on other devices
How to cite this article
Kaur K, Starr DM. Life-threatening retroperitoneal bleeding in coronavirus disease 2019 patient while on full dose anticoagulation: A case report. Int J Case Rep Images 2022;13(2):86–90.ABSTRACT
Introduction: Thromboembolism is one of the common complications in patients presenting with coronavirus disease 2019. Studies on coronavirus disease 2019 patients recommend the use of anticoagulation to prevent thrombotic complications in these patients and have shown to decrease mortality. However, spontaneous retroperitoneal bleeding is one of the life-threatening complications of therapeutic anticoagulation.
Case Report: This case report is about an 82-year-old male who was admitted for coronavirus disease 2019 pneumonia, started on therapeutic dose anticoagulation on presentation, and developed life-threatening retroperitoneal bleeding. He was managed with conservative treatment because of the advanced age of the patient, high risk of deterioration, and guarded prognosis.
Conclusion: Although anticoagulation protects against the thrombotic complications of coronavirus-19 infection, it has life-threatening bleeding complications. The use of anticoagulation in these patients should be practiced with caution while monitoring for bleeding complications. There needs to be more clinical studies and trials to assess the risk-benefit ratio of anticoagulation in coronavirus disease 2019 patients.
Keywords: Anticoagulant, COVID-19, Hemorrhage, Retroperitoneal space
SUPPORTING INFORMATION
Author Contributions
Kirandeep Kaur - Substantial contributions to conception and design, Acquisition of data, Analysis of data, Interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published
Dennis M Starr - Substantial contributions to conception and design, Acquisition of data, Analysis of data, Interpretation of data, Drafting the article, Revising it critically for important intellectual content, Final approval of the version to be published
Guaranter of SubmissionThe corresponding author is the guarantor of submission.
Source of SupportNone
Consent StatementWritten informed consent was obtained from the patient for publication of this article.
Data AvailabilityAll relevant data are within the paper and its Supporting Information files.
Conflict of InterestAuthors declare no conflict of interest.
Copyright© 2022 Kirandeep Kaur et al. This article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information.
